Magnesium ammonium phosphate cement composition

Abstract

This invention relates to a cement, which comprises in its main phase of microcrystalline magnesium ammonium phosphate and nanoapatite after hardening and thus at the same time has considerable strength. The material is biologically degradable and is suitable for application in tooth cements, as bone replacement, as bone filler, as bone cement or as bone adhesive.

1 - 44 . (canceled) 
   
   
       45 . A magnesium ammonium phosphate cement produced by a process comprising:
 providing an ammonium salt;   providing a powder mixture having molar quantities of the components calcium (Ca), magnesium (Mg) and orthophosphate (P) in the mixture in the ranges 1.00<Ca/P<1.50 and 0<Mg/P<0.50;   mixing the ammonium salt and the powder mixture with a mixing liquid to form a paste and achieve an uniform distribution of the liquid in the powder mixture; and   reacting the components therein to form a microcrystalline magnesium ammonium phosphate cement.   
   
   
       46 . The magnesium ammonium phosphate cement of  claim 45 , further comprising providing a strontium salt. 
   
   
       47 . The magnesium ammonium phosphate cement of  claim 46 , wherein the strontium salt comprises SrCO 3 . 
   
   
       48 . The magnesium ammonium phosphate cement of  claim 47 , comprising providing the SrCO 3  in a quantity of 0.01 to 10 wt. % based on the total weight of the preparation. 
   
   
       49 . The magnesium ammonium phosphate cement of  claim 45 , comprising providing the ammonium salt as (NH 4 ) 2 HPO 4 . 
   
   
       50 . The magnesium ammonium phosphate cement of  claim 45 , comprising reacting the components therein between about 2.5 to about 60 minutes (measured according to ASTM C266-89) to form the magnesium ammonium phosphate cement. 
   
   
       51 . The magnesium ammonium phosphate cement of  claim 45 , further comprising providing granular particles. 
   
   
       52 . The magnesium ammonium phosphate cement of  claim 51 , wherein the granular particles are slightly soluble in aqueous liquids. 
   
   
       53 . The preparation of  claim 51 , comprising providing granular particles having a diameter of between 10 μm and 300 μm. 
   
   
       54 . The magnesium ammonium phosphate cement of  claim 51 , wherein the granular particles are a substance selected from the group consisting of NaCl, sugars, CaSO 4 , β-TCP, polylactides, polyglycolides or polylactide/polyglycolide copolymer, CaCO 3  and CaHPO 4 . 
   
   
       55 . The magnesium ammonium phosphate cement of  claim 45 , further comprising adding a pharmaceutical and/or a bioactive active ingredient. 
   
   
       56 . The magnesium ammonium phosphate cement of  claim 55 , wherein the pharmaceutical and/or a bioactive active ingredient comprises a therapeutic dose of a component selected from the group consisting of antibiotics, cytostatic agents, analgesics, disinfectants, growth factors, proteins and elastin inhibitors. 
   
   
       57 . The magnesium ammonium phosphate cement of  claim 45 , comprising providing a powder mixture having α-tricalcium phosphate.